NewEdge Advisors’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-61,088
Closed -$726K 3962
2024
Q4
$726K Sell
61,088
-4,128
-6% -$70.4K ﹤0.01% 1336
2024
Q3
$1.81M Buy
65,216
+12,142
+23% +$304K 0.01% 837
2024
Q2
$1.27M Buy
+53,074
New +$1.25M 0.01% 955
2024
Q1
Sell
-3
Closed -$47 3824
2023
Q4
$47 Hold
3
﹤0.01% 3672
2023
Q3
$26 Sell
3
-144
-98% -$1.02K ﹤0.01% 3420
2023
Q2
$1.16K Buy
147
+34
+30% +$237 ﹤0.01% 3216
2023
Q1
$843 Buy
113
+15
+15% +$149 ﹤0.01% 3181
2022
Q4
$1 Buy
+98
New +$1.12K ﹤0.01% 3980

Other funds holding ASPN

NewEdge Advisors's ASPN Position: Q1 2025 in Review

NewEdge Advisors sold out of Aspen Aerogels (ASPN) in Q1 2025, closing a stake of 61,088 shares — an estimated $726K sold.

NewEdge Advisors first reported a position in ASPN in Q4 2022 and held it in 8 quarters. The position peaked at $1.81M in Q3 2024. 221 funds tracked by Wall St. Rank hold ASPN as of Q1 2025.

  • NewEdge Advisors reported no remaining Aspen Aerogels position as of Q1 2025 after selling out during the quarter.
  • NewEdge Advisors sold 61,088 Aspen Aerogels shares in Q1 2025, an estimated $726K.
  • NewEdge Advisors first reported a position in Aspen Aerogels in Q4 2022 and held it in 8 quarters.
  • NewEdge Advisors's Aspen Aerogels position peaked at $1.81M in Q3 2024.
  • 221 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2025.

Based on NewEdge Advisors's 13F filing for Q1 2025, filed 15 May 2025.